Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Free Cash Flow (2023 - 2025)

Fractyl Health (GUTS) has disclosed Free Cash Flow for 3 consecutive years, with -$22.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow fell 24.49% year-over-year to -$22.7 million, compared with a TTM value of -$86.8 million through Sep 2025, down 43.53%, and an annual FY2024 reading of -$67.3 million, down 56.79% over the prior year.
  • Free Cash Flow was -$22.7 million for Q3 2025 at Fractyl Health, down from -$21.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$9.6 million in Q1 2023 and bottomed at -$25.5 million in Q1 2025.
  • Average Free Cash Flow over 3 years is -$16.3 million, with a median of -$17.3 million recorded in 2024.
  • Peak annual rise in Free Cash Flow hit 12.11% in 2025, while the deepest fall reached 99.9% in 2025.
  • Year by year, Free Cash Flow stood at -$10.5 million in 2023, then crashed by 64.97% to -$17.3 million in 2024, then tumbled by 31.59% to -$22.7 million in 2025.
  • Business Quant data shows Free Cash Flow for GUTS at -$22.7 million in Q3 2025, -$21.3 million in Q2 2025, and -$25.5 million in Q1 2025.